The epidemiology of triple-negative breast cancer, including race - Test2 - elhamkhani - TriplyDB

The epidemiology of triple-negative breast cancer, including race

The epidemiology of triple-negative breast cancer, including race

http://www.wikidata.org/entity/Q24289471

about

Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis Breast cancer subtypes and previously established genetic risk factors: a bayesian approach Breast cancer pathology, receptor status, and patterns of metastasis in a rural Appalachian population Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling.Reproductive risk factors and breast cancer subtypes: a review of the literature.Hypothesized role of pregnancy hormones on HER2+ breast tumor development.Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study Association between oral contraceptive use as a risk factor and triple-negative breast cancer: A systematic review and meta-analysis.Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis.Weight Loss Reversed Obesity-Induced HGF/c-Met Pathway and Basal-Like Breast Cancer Progression Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches Breast feeding, parity and breast cancer subtypes in a Spanish cohort Obesity-mediated regulation of HGF/c-Met is associated with reduced basal-like breast cancer latency in parous mice.Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer.Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women.Management options in triple-negative breast cancer Parity and lactation in relation to estrogen receptor negative breast cancer in African American women.Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010.Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.Triple-Negative Breast Cancer: Clinical and Histological Correlations.Cancer immunology--analysis of host and tumor factors for personalized medicine.Triple-negative breast cancer: adjuvant therapeutic options.Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study.Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer.Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.Early-Life Socioeconomic Status and the Prevalence of Breast Cancer in Later Life.Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.

P2860

Q26744566-03F2E8EB-756F-4F64-9952-C0CDFCA13731 Q27011535-08A65AD6-DF3A-482C-AB4F-D2BC1361514D Q28076106-CF22F49C-AAE9-49BE-8C16-627720811E59 Q28085555-F3A281A9-BD29-4436-A4E0-5DDBB6066ADB Q28397311-498E8403-2068-4499-BE12-44C0BF30E521 Q29006708-5551464E-611C-42C3-81C8-EC56F51085BD Q31102636-D5420795-2656-44F6-A87C-9B955EC428DF Q33596695-89C5DFFE-70BA-4E80-A83F-A6FF4AF37215 Q33618393-D45CC4FB-4080-40FE-B719-10F73FA3D290 Q33632008-591A22DD-2EBE-4524-9253-852E1D25E9DC Q33745434-0620A568-CE13-4E2F-99DE-910BE1B97EBC Q33758934-0E851676-D698-4D56-8265-DFE4C41747A4 Q33857861-6D54BF72-D4B3-475B-9753-194EE96238E1 Q33859673-81C130DC-C507-47C0-8697-954D761690DD Q33859809-029E19AE-2A99-4C58-A0BE-93A08B5970A8 Q33874970-69C90852-54CF-417D-AA54-79F6F2E07260 Q34119028-5463BCBC-3C25-4BD4-88C8-5C36D742C648 Q34336498-F6BEB23A-A1EC-4683-B991-3C83ABEB73E4 Q34420979-69FD432E-EE57-4BBD-BDDC-907BD496B000 Q34590295-8093B725-6784-4A0F-8F62-AB877C5307B3 Q34619821-2CA997AE-D6C0-4BB0-AFE1-AFC0F1864A1D Q34677207-3B2E444C-CC09-487C-88E2-1D67F6187275 Q34705321-0ADAEC6D-0222-45A0-B1CA-99AF14083411 Q34722266-AA5742D5-B066-4FCB-8CF5-4BE61695BD8A Q34736954-27A16968-A1FD-4A73-A9C3-B847751DE640 Q35000223-2AAE44D3-1ED4-4B96-9CAE-CC32D23B2EC5 Q35155460-824E29FC-77AF-432D-A6D2-377753504813 Q35229557-83E69465-06A3-4467-ADED-CA02CB4AA281 Q35437586-34710B38-C669-4048-B1EC-8168B507B965 Q35558962-FD3C739A-6B58-4FBB-BE7E-24E6604BED3B Q35565644-ED287271-4CD0-48C5-B81B-8EF01E5A84EF Q35573190-FDDEDD19-74D2-4AFC-8163-990DEE53336B Q35576252-093C3454-7449-45DB-A409-BCF6B04B2A40 Q35583180-E111F7C8-4809-42A9-B8E8-7AF2AE490E8F Q35692146-10F83E95-1E21-4AF3-913E-9056CE97842D Q35694329-1588946E-7CAA-4402-82A5-8EC41E789A54 Q35918620-8F3FFB87-04A1-4E47-A020-147715B96B4D Q35928943-9D70C1E6-9555-4A91-882E-A474C5A51288 Q36191310-4C469F20-8D14-40EE-AD7B-A40BD7A34B57 Q36272043-53627406-D2FD-46C1-85A3-A2708F1ECBE6

P2860

The epidemiology of triple-negative breast cancer, including race

http://www.wikidata.org/entity/Q24289471

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The epidemiology of triple-negative breast cancer, including race

@ast

The epidemiology of triple-negative breast cancer, including race

@en

The epidemiology of triple-negative breast cancer, including race

@en-gb

The epidemiology of triple-negative breast cancer, including race

@nl

type

label

The epidemiology of triple-negative breast cancer, including race

@ast

The epidemiology of triple-negative breast cancer, including race

@en

The epidemiology of triple-negative breast cancer, including race

@en-gb

The epidemiology of triple-negative breast cancer, including race

@nl

prefLabel

The epidemiology of triple-negative breast cancer, including race

@ast

The epidemiology of triple-negative breast cancer, including race

@en

The epidemiology of triple-negative breast cancer, including race

@en-gb

The epidemiology of triple-negative breast cancer, including race

@nl

P1433

Q24289471-7883868E-7EEA-4BB1-A0F6-21018FFBB4CB

P1476

Q24289471-25AFFC67-C76E-4006-A6D9-BD2DE5E6895E

P2093

Q24289471-6C68E93B-C035-473F-9D3E-B3589C45D060

Q24289471-738F3CCA-3B80-4AD7-9040-7A40C50502A4

Q24289471-7EB7541D-41A8-46F7-B67D-65D6A343AB80

Q24289471-89015A13-B975-42E1-A912-F94C35011847

Q24289471-BC736BA0-33FF-4CE7-B6AD-34A19AA308C7

Q24289471-CC030AC8-55A9-46F0-8729-97141C972F95

Q24289471-D5B6E3E9-27FB-4B0E-B63F-350FD37EDEB5

P2860

Q24289471-00F3B36F-B15A-478E-AAAB-9685907CB7FB

Q24289471-1EC6A15B-B76E-4AEC-896F-5638E7E65233

Q24289471-2231FF56-5E26-438F-8380-628E79E6E8DA

Q24289471-27B34776-CD67-4DA4-ABCC-6E85629C7DEC

Q24289471-2BF80B00-8B0A-4B3F-B8E0-71CEF7636F7D

Q24289471-2F470457-1AA6-4CE0-9891-5887E2729BC9

Q24289471-3246BD5C-56BA-4CBC-B94E-D31DD0CA7661

Q24289471-39B48477-BC7B-423B-A69F-BAD4AB312733

Q24289471-510C649A-8FC3-4404-ADF3-0D9FB7ECCAA5

Q24289471-5294A633-BA7A-49FF-93D8-4FDB27922AC1

P2888

Q24289471-74DA8209-40CE-488A-8AFA-151C8FFAA5CF

P304

Q24289471-AFCA3ECB-DA5A-49F0-8599-6F88C8FC57F4

P31

Q24289471-A1F2529C-24FC-4C13-A836-F829EC47F388

P3181

Q24289471-093D1F7F-DE34-43F3-B01B-5A60F542C294

P356

Q24289471-F9CD06A6-B345-4DA1-86BC-FB170BD6CB6B

P407

Q24289471-F671CC80-89FA-4ACB-9208-B967C3B04C5A

P433

Q24289471-DFA1B8A9-4915-4FC6-8A13-1C0415B79769

P478

Q24289471-598FFE4B-0BB2-4ECC-B396-7CF3C3BA8503

P577

Q24289471-DF28FA1F-7990-4E0D-81CE-04A78B1ECDC1

P6179

Q24289471-85360EB1-6585-44ED-804D-7259C4570C06

P698

Q24289471-FA8D0A9E-6348-4C0E-8262-17DD64023738

P921

Q24289471-A215F655-C18A-4658-B4A3-5C8D850FC43F

P932

Q24289471-86690346-F72F-4D6A-A33F-1320876050DF

P3181

P356

S10552-009-9331-1

P1433

Cancer Causes & Control

P1476

The epidemiology of triple-negative breast cancer, including race

@en

P2093

Elaine W Flagg

http://www.w3.org/2001/XMLSchema#string

J William Eley

http://www.w3.org/2001/XMLSchema#string

Jonathan M Liff

http://www.w3.org/2001/XMLSchema#string

Katrina F Trivers

http://www.w3.org/2001/XMLSchema#string

Mary Jo Lund

http://www.w3.org/2001/XMLSchema#string

Peggy L Porter

http://www.w3.org/2001/XMLSchema#string

Ralph J Coates

http://www.w3.org/2001/XMLSchema#string

P2860

Why most published research findings are false

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology

Epidemiology of basal-like breast cancer.

P2888

s10552-009-9331-1

P304

1071-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1789148

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S10552-009-9331-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1014892537

http://www.w3.org/2001/XMLSchema#string

P698

19343511

http://www.w3.org/2001/XMLSchema#string

P921

P932

4852686

http://www.w3.org/2001/XMLSchema#string